Enzo Health raises $20M Series A to modernize home health with an AI-native platform, addressing workforce shortages, regulatory complexity, and surging demand as aging demographics accelerate the shift to in-home care.
Lehi, Utah — May 4, 2026
Enzo Health, a Lehi, Utah-based AI-driven platform for home health and post-acute care, has raised a $20 million Series A led by N47 (Palo Alto), bringing total funding to $26 million. Existing investors Gradient (Palo Alto, a Google-affiliated investment firm), Tandem Ventures (Draper, UT), and Rigby Watts (Millcreek, UT) also participated.
The raise comes at a pivotal moment for the U.S. healthcare system. More than 10,000 Americans turn 65 each day, according to the U.S. Department of Health and Human Services, and roughly 70% will require long-term care at some point in their lives. At the same time, the Bureau of Labor Statistics projects home health roles will grow by about 17% over the next decade.
A Sector Under Pressure
Despite rising demand, home health providers face mounting operational strain. Medicare reimbursement cuts, tightening regulations, and severe workforce shortages are compressing margins. Industry data from the Home Care Association of America shows clinician turnover nearing 80% within the first 100 days, driven largely by administrative overload.
Much of that burden stems from outdated software infrastructure. Many agencies still rely on fragmented systems originally designed for a pre-digital workflow era, where fax machines were central to operations, forcing clinicians to juggle documentation, compliance, and patient care simultaneously.
Enzo’s AI-Native Approach
Founded in 2024, Enzo Health is positioning itself as a full-stack alternative. Its platform integrates front office, clinical, and back-office operations into a single system, automating workflows from referral intake through reimbursement.
Key components include:
The goal is straightforward: reduce administrative overhead, improve reimbursement accuracy, and give clinicians more time with patients.
CEO and co-founder Zach Newman framed the problem this way:
“Home health is one of the fastest-growing segments in healthcare, but agencies are being squeezed from every direction. The systems they rely on were never built for today’s complexity.”
Rapid Growth Signals Market Fit
Enzo reports more than 40x revenue growth over the past 12 months, with its platform now used by organizations serving over 500,000 patients annually. That pace suggests strong demand for infrastructure-level solutions rather than incremental tools.
Investors are betting on that thesis.
“By building an AI-native platform from the ground up, Enzo is enabling a level of automation and efficiency that legacy systems simply can’t match,” said Vivian Cheng, Partner at N47.
Similarly, Andrew Brackin, Partner at Gradient, emphasized the shift away from point solutions:
“The category does not need another disconnected AI tool. It needs a platform.”
Why This Raise Matters
Enzo’s funding highlights a broader trend: AI is moving from assistive tools to core infrastructure in healthcare operations.
While much of the recent AI hype has centered on diagnostics and clinical decision-making, the bigger near-term opportunity may lie in administrative automation, a segment estimated to account for nearly a quarter of U.S. healthcare spending.
Home health, in particular, is a prime target:
By tackling workflow end-to-end, Enzo is aiming to become the system of record for post-acute care providers, a position historically dominated by legacy vendors with limited modernization.
What’s Next
Enzo says it plans to use the new capital to expand beyond home health into skilled nursing and hospice, extending its platform to adjacent post-acute care segments facing similar operational challenges.
If successful, the company could help redefine how care is delivered outside hospital settings where an increasing share of healthcare is expected to move over the next decade.
Learn more at www.enzo.health/blog